Medical Waste Management Market to Reach $19.4 Billion by 2035 | Stericycle, Clean Harbors, Veolia, WM Lead Consolidating Sector

The global medical waste management market, valued at USD 5.1 billion in 2024 and projected to reach USD 5.5 billion in 2025, will grow to USD 19.4 billion by 2035, at a compound annual growth rate (CAGR) of 13.4% over the 2025 to 2035 forecast period. Accelerating healthcare infrastructure investment, a surge in infectious disease research, and tightening regulatory mandates are together creating a sustained, decade-long growth cycle for providers of collection, treatment, recycling, and disposal services worldwide.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/medical-waste-management-market/request-sample.html

Market Overview: Why Medical Waste Management Is a High-Priority Sector
The World Health Organization estimates that 15 to 20% of all healthcare-generated waste qualifies as hazardous, infectious, or radioactive. In the United States alone, more than 6 million tonnes of healthcare waste is generated annually, and the global total increases by 2 to 3% every year. That volume creates direct risks for health workers, patients, waste handlers, and surrounding communities, and hospitals, pharmaceutical companies, and diagnostic labs are increasingly outsourcing end-to-end waste management rather than managing fragmented in-house programs.

Medical waste management service providers cover the full chain from point-of-generation pickup to final certified disposal, complying with mandates set by bodies such as the U.S. Environmental Protection Agency, the Occupational Safety and Health Administration, and the European Environment Agency. Beyond regulatory compliance, outsourcing reduces the high capital and operational costs of specialized treatment equipment, shortens waste management timelines, and transfers liability.

Recent developments underscore just how active this market has become. In June 2025, WM completed its acquisition of Stericycle to strengthen its regulated medical waste operations. In April 2025, Clean Harbors acquired Bio-Medical Waste Solutions for USD 150 million to expand its geographic reach and service depth. In March 2025, Veolia acquired three companies, including Ingenium, New England Disposal Technologies, and New England MedWaste, to add high-temperature treatment capacity in northeastern U.S. markets. These are not isolated moves; they reflect a sector-wide acknowledgment that scale, technology, and regulatory expertise now define competitive advantage.

Key Growth Drivers
Rising Infectious Disease Burden and Healthcare Utilization The ongoing expansion of diagnostics for chronic and infectious diseases produces a continuous stream of contaminated samples, sharps, and pharmaceutical residues. Countries with dense populations, limited hygiene infrastructure, and high resource constraints face disproportionately high hazardous waste accumulation, and even in high-income markets, increasing surgical volumes and outpatient procedures generate more regulated waste per capita each year.
Stricter Regulatory Enforcement Across Major Markets Government agencies in North America and Europe have progressively tightened requirements for segregation, chain-of-custody documentation, and certified disposal. Healthcare facilities that fail compliance inspections face fines and license risks, pushing procurement decisions toward established, certified third-party operators rather than informal or in-house arrangements.

Growing Geriatric Population and Chronic Disease Prevalence An aging global population directly correlates with higher utilization of hospitals, dialysis centers, and long-term care facilities, all of which are significant waste generators. Conditions such as chronic kidney disease, diabetes, and cancer require sustained treatment regimens that continuously produce regulated waste, creating predictable, recurring revenue for waste management providers.
M&A Activity Consolidating a Fragmented Market Over 95 companies actively compete in this market, with more than 65% of them headquartered in North America. The wave of acquisitions completed in 2025, spanning WM/Stericycle, Clean Harbors/Bio-Medical Waste Solutions, and Veolia's three-company purchase, reflects investor confidence in sector growth while simultaneously reducing fragmentation and raising service quality benchmarks.

International Capacity Building and Public-Private Collaboration In September 2025, the United Nations Office for Project Services and Takeda Pharmaceutical announced a joint initiative to establish six medical waste treatment facilities in Bangladesh and train healthcare and waste workers in proper handling protocols. Such programs expand the addressable market in lower-income regions while raising baseline compliance standards, creating long-term demand for equipment, services, and training.

Market Segmentation: Treatment and Hazardous Waste Dominate
By service type, the treatment segment holds the largest share at 50% of the 2024 market, reflecting the considerable cost and equipment intensity of rendering waste safe for final disposal. Collection, recycling, and disposal account for the remainder. By treatment method, incineration captures 55% of the 2025 market, owing to its capacity to handle all categories of hazardous waste at scale. The fastest-growing treatment method is autoclave and steam processing, which is expected to grow at a CAGR of 17% through 2035 as smaller healthcare facilities adopt it for on-site use due to its lower capital cost and operational simplicity.

On the waste type dimension, hazardous waste commands 90% of the market. Although hazardous and infectious waste represents a smaller share of total waste volume, its handling complexity and regulatory requirements make it the primary revenue driver. The infectious waste category alone accounts for 30% of market share by waste category. By treatment site, off-site services hold approximately 65% of market share in 2025; however, on-site treatment is the faster-growing sub-segment, as facilities seek to reduce transport risk and operational costs.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/medical-waste-management-market/request-quote.html

Regional Insights: North America Leads, Asia-Pacific Accelerates
North America accounts for approximately 70% of the global medical waste management market in 2025, a position built on strong government enforcement infrastructure, high per-capita healthcare spending, and decades of established service networks. Regulatory bodies such as the EPA and OSHA maintain stringent oversight, and the volume of surgical procedures performed annually in the U.S. ensures consistent, high-value waste streams for certified operators.
Asia-Pacific is the fastest-growing regional market, with a projected CAGR of 14% through 2035. Rapid hospital construction, government-led public health initiatives, a rising middle class seeking better healthcare access, and growing awareness of environmental and occupational hazards are all accelerating demand. International programs, including the UNOPS-Takeda collaboration in Bangladesh, signal that multilateral institutions now treat healthcare waste infrastructure as a development priority across the region. Europe holds the third-largest share, supported by the European Environment Agency's waste management directives, while Latin America and the Middle East and North Africa represent emerging markets with improving regulatory frameworks.

Competitive Landscape: Scale and M&A Define the Battleground
Key players profiled in the Roots Analysis report include Averda, Clean Harbors, GreenTech Environ Management, Medicare, MedPro Disposal, REMONDIS Mendison, Stericycle, Triumvirate Environmental, Veolia Environmental Services, and WM, among 95 or more companies tracked in the full database. The market is well-fragmented, with small, mid-sized, large, and very large companies all competing across healthcare verticals including hospitals, pharmaceutical manufacturers, clinics, and laboratories.

The primary competitive battleground is now scale combined with treatment technology breadth. Larger operators are acquiring regional specialists to gain geographic density, specialized permits, and treatment capacity. Smaller companies compete on service responsiveness and pricing in local markets. With over 95% of active players concentrated in hazardous and infectious waste management, differentiation through specialty services, such as pharmaceutical or pathological waste disposal, is emerging as a secondary competitive dimension.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/medical-waste-management-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.